← Back to Clinical Trials
Recruiting NCT06066918
Prophylactic Pregabalin Treatment Following Spinal Cord Injury
Trial Parameters
Condition Spinal Cord Injuries
Sponsor Loewenstein Hospital
Study Type INTERVENTIONAL
Phase N/A
Enrollment 50
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2021-07-13
Completion 2026-02-05
All Conditions
Interventions
Pregabalin 75mg
Brief Summary
Patients arriving to rehabilitation up to 3 months following SCI will be given (study group) or not (control group) Lyrica (75X2). They will be followed for central pain development.
Eligibility Criteria
Inclusion Criteria: * Up to 3 months following traumatic or non-traumatic SCL * Ability to give informed consent and cooperate Exclusion Criteria: * Pregnancy * Neurological or other medical conditions that may interfere with sensation * Neuropathic-like pain before recruitment (described as painful sensation of electric current, burning, numbness, tingling, pricking, or squeezing) * Being treated with Pregabalin * Blood creatinine levels \>1.2 or creatinine clearance \<60 * Sensitivity to lactose